Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy
Authors:
- 3 July 2020
- journal article
- other
- Published by Taylor & Francis in Expert Review of Medical Devices
- Vol. 17 (7) , 707-720
Abstract
Type 1 diabetes is a lifelong disease with high management burden. The majority of people with type 1 diabetes fail to achieve glycemic targets. Algorithm-driven automated insulin delivery (closed-...Keywords
Funding Information
- National Institute of Health Research Cambridge Biomedical Research Centre
This publication has 74 references indexed in Scilit:
- Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical TrialDiabetes Care, 2014
- Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control studyDiabetologia, 2013
- Threshold-Based Insulin-Pump Interruption for Reduction of HypoglycemiaNew England Journal of Medicine, 2013
- Clinical Evaluation of a Personalized Artificial PancreasDiabetes Care, 2013
- Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes CampNew England Journal of Medicine, 2013
- Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesBMJ, 2011
- MD-Logic Artificial Pancreas SystemDiabetes Care, 2010
- Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitusCochrane Database of Systematic Reviews, 2010
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial PancreasDiabetes Care, 2008
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993